Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lymphoma, Non-Hodgkin 4Leukemia 4Pain 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, B-Cell 3Lymphoma 3Hodgkin Disease 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Leukemia, Hairy Cell 2Hematologic Neoplasms 2Carcinoma in Situ 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Trigger Finger Disorder 1Small Cell Lung Carcinoma 1Sarcoma, Alveolar Soft Part 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Philadelphia Chromosome 1Patient Satisfaction 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Cisplatin 4Pemetrexed 3Etoposide 3Topotecan 2Gemcitabine 2Carboplatin 2vosaroxin 1vinflunine 1veliparib 1taxane 1pomalidomide 1pembrolizumab 1liposomal doxorubicin 1etoposide phosphate 1enzalutamide 1apalutamide 1abiraterone 1Vinorelbine 1Tomography, X-Ray Computed 1Temozolomide 1Radiation 1RRx-001 1Positron-Emission Tomography 1Podophyllotoxin 1Platinum 1Paclitaxel 1Irinotecan 1Histamine Antagonists 1GSK2879552 1Epinephrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Small Cell × Acetaminophen × Clear all
NCT03554473 2025-05-09

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
37 enrolled 19 charts
Thoracic

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡